 Anthranilic acid GW9371 identified novel class PPARdelta partial agonist high-throughput screening. design synthesis SAR analogues described. GSK1115 GSK7227 show potent partial agonism PPARdelta target genes CPT1a PDK4 skeletal muscle cells.